相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multiple Topoisomerase I (TopoI), Topoisomerase II (TopoII) and Tyrosyl-DNA Phosphodiesterase (TDP) inhibitors in the development of anticancer drugs
Emma Baglini et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Dual Inhibitors of Human DNA Topoisomerase II and Other Cancer Related Targets
Ziga Skok et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Specific Roles of HSP27 S15 Phosphorylation Augmenting the Nuclear Function of HER2 to Promote Trastuzumab Resistance
Soo-Yeon Hwang et al.
CANCERS (2020)
DNA double-strand breaks induce H2Ax phosphorylation domains in a contact-dependent manner
Patrick L. Collins et al.
NATURE COMMUNICATIONS (2020)
Dual Inhibitors as a New Challenge for Cancer Multidrug Resistance Treatment
Tijana Stankovic et al.
CURRENT MEDICINAL CHEMISTRY (2019)
The antitumor activity of CYB-L10, a human topoisomerase IB catalytic inhibitor
Qian Yu et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
Recent Advances in Use of Topoisomerase Inhibitors in Combination Cancer Therapy
Wenjie Wang et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)
A comprehensive review of topoisomerase inhibitors as anticancer agents in the past decade
Xiaoxia Liang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery and Biological Evaluations of Halogenated 2,4-Diphenyl Indeno[1,2-b]pyridinol Derivatives as Potent Topoisomerase IIα-Targeted Chemotherapeutic Agents for Breast Cancer
Tara Man Kadayat et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Broken by the Cut: A Journey into the Role of Topoisomerase II in DNA Fragility
Naomi D. Atkin et al.
GENES (2019)
A chromenone analog as an ATP-competitive, DNA non-intercalative topoisomerase II catalytic inhibitor with preferences toward the alpha isoform
Seojeong Park et al.
CHEMICAL COMMUNICATIONS (2019)
New tanshinone I derivatives S222 and S439 similarly inhibit topoisomerase I/II but reveal different p53-dependency in inducing G2/M arrest and apoptosis
Qian-Ting Tian et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
Nicholas A. Meanwell
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Monoubiquitinated gamma-H2AX: Abundant product and specific biomarker for non-apoptotic DNA double-strand breaks
Michal W. Luczak et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
A Multiplexed Screening Assay to Evaluate Chemotherapy-Induced Myelosuppression Using Healthy Peripheral Blood and Bone Marrow
Komal K. Javarappa et al.
SLAS DISCOVERY (2018)
A new phenolic series of indenopyridinone as topoisomerase inhibitors: Design, synthesis, and structure-activity relationships
Aarajana Shrestha et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Recent developments in topoisomerase-targeted cancer chemotherapy
Kirk E. Hevener et al.
ACTA PHARMACEUTICA SINICA B (2018)
Discovery and structure-activity relationship studies of 2-benzylidene-2,3-dihydro-1H-inden-1-one and benzofuran-3(2H)-one derivatives as a novel class of potential therapeutics for inflammatory bowel disease
Tara Man Kadayat et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor
Seojeong Park et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines: Topoisomerase I and IIα dual inhibitors with DNA non-intercalative catalytic activity
Ganesh Bist et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Meroterpenoids with Antitumor Activities from Guava (Psidium guajava)
Xu-Jie Qin et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2017)
Physiological functions of programmed DNA breaks in signal-induced transcription
Janusz Puc et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
2-Chlorophenyl-substituted benzofuro[3,2-b] pyridines with enhanced topoisomerase inhibitory activity: The role of the chlorine substituent
Til Bahadur Thapa Magar et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
A novel indeno[1,2-b]pyridinone derivative, a DNA intercalative human topoisomerase IIα catalytic inhibitor, for caspase 3-independent anticancer activity
K. H. Jeon et al.
CHEMICAL COMMUNICATIONS (2017)
Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of 2-phenyl- or hydroxylated 2-phenyl-4-aryl-5H-indeno[1,2-b]pyridines
Tara Man Kadayat et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Modified 2,4-diaryl-5H-indeno[1,2-b]pyridines with hydroxyl and chlorine moiety: Synthesis, anticancer activity, and structure-activity relationship study
Tara Man Kadayat et al.
BIOORGANIC CHEMISTRY (2015)
Synthesis and biological evaluation of 6-substituted indolizinoquinolinediones as catalytic DNA topoisomerase I inhibitors
Le-Mao Yu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Applications of Fluorine in Medicinal Chemistry
Eric P. Gillis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
A Series of Novel Terpyridine-Skeleton Molecule Derivants Inhibit Tumor Growth and Metastasis by Targeting Topoisomerases
Han-Byeol Kwon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
A New-Class Antibacterial-Almost. Lessons in Drug Discovery and Development: A Critical Analysis of More than 50 Years of Effort toward ATPase Inhibitors of DNA Gyrase and Topoisomerase IV
Gregory S. Bisacchi et al.
ACS INFECTIOUS DISEASES (2015)
HU-331 Is a Catalytic Inhibitor of Topoisomerase Ilα
Kellie M. Regal et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2014)
Drugging Topoisomerases: Lessons and Challenges
Yves Pommier
ACS CHEMICAL BIOLOGY (2013)
Topoisomerase I inhibition in colorectal cancer: biomarkers and therapeutic targets
D. C. Gilbert et al.
BRITISH JOURNAL OF CANCER (2012)
Development and Validation of an Immunoassay for Quantification of Topoisomerase I in Solid Tumor Tissues
Thomas D. Pfister et al.
PLOS ONE (2012)
Salubrious effects of dexrazoxane against teniposide-induced DNA damage and programmed cell death in murine marrow cells
S. A. Bakheet et al.
MUTAGENESIS (2011)
A Novel DNA Topoisomerase I Inhibitor with Different Mechanism from Camptothecin Induces G2/M Phase Cell Cycle Arrest to K562 Cells
Ning Wu et al.
BIOCHEMISTRY (2010)
A Distinctive DNA Damage Response in Human Hematopoietic Stem Cells Reveals an Apoptosis-Independent Role for p53 in Self-Renewal
Michael Milyavsky et al.
CELL STEM CELL (2010)
Halogen Atoms in the Modern Medicinal Chemistry: Hints for the Drug Design
Marcelo Zaldini Hernandes et al.
CURRENT DRUG TARGETS (2010)
Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs
S. Salerno et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Protection of mouse bone marrow from etoposide-induced genomic damage by dexrazoxane
Sabry M. Attia et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity
Thomas D. Pfister et al.
MOLECULAR CANCER THERAPEUTICS (2009)
The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing
Joseph E. Deweese et al.
NUCLEIC ACIDS RESEARCH (2009)
DNA topoisomerases: harnessing and constraining energy to govern chromosome topology
Allyn J. Schoeffler et al.
QUARTERLY REVIEWS OF BIOPHYSICS (2008)
Betulinic acid, a catalytic inhibitor of topoisomerase I, inhibits reactive oxygen species-mediated apoptotic topolsomerase I-DNA cleavable complex formation in prostate cancer cells but does not affect the process of cell death
Agneyo Ganguly et al.
CANCER RESEARCH (2007)
Batracylin (NSC 320846), a dual inhibitor of DNA Topoisomerases I and II induces histone γ-H2AX as a biomarker of DNA damage
V. Ashutosh Rao et al.
CANCER RESEARCH (2007)
An efficient and expeditious microwave-assisted synthesis of 4-azafluorenones via a multi-component reaction
Shujiang Tu et al.
TETRAHEDRON LETTERS (2007)
Molecular field extrema as descriptors of biological activity: Definition and validation
T Cheeseright et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2006)
Stringent regulation of DNA repair during human hematopoietic differentiation: A gene expression and functional analysis
Tomke U. Bracker et al.
STEM CELLS (2006)
Genotoxicity of etoposide:: greater susceptibility of MLL than other target genes
A Ng et al.
CANCER GENETICS AND CYTOGENETICS (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Dexrazoxane protects against myelosuppression from the DNA cleavage-enhancing drugs etoposide and daunorubicin but not doxorubicin
KF Hofland et al.
CLINICAL CANCER RESEARCH (2005)
Dexrazoxane - A review of its use for cardioprotection during anthracycline chemotherapy
RS Cvetkokic et al.
DRUGS (2005)
Catalytic topoisomerase II inhibitors in cancer therapy
AK Larsen et al.
PHARMACOLOGY & THERAPEUTICS (2003)
Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes
AM Wilstermann et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2003)
Cellular roles of DNA topoisomerases: A molecular perspective
JC Wang
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Topoisomerase II inhibitor-related acute myeloid leukaemia
CH Pui et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
分享论文
